Abstract
Aurora B is a serine-threonine kinase belonging to the highly conserved Aurora family of mitotic kinases. Aurora B is a chromosomal passenger protein involved in chromosome segregation, spindle-checkpoint, and cytokinesis. Alteration of each of these steps could induce aneuploidy, one of main features, and driving force of cancer progression. The overexpression of Aurora B has been observed in several tumor types, and has been linked with a poor prognosis of cancer patients. In this review we will focus on the role of Aurora B in cancer development, its role as a prognostic marker, and the clinical outcome of recently developed Aurora(s) inhibitors.
Keywords: Aurora kinase, Aurora B, serine-threonine kinase, mitosis, cytokinesis, cancer, inhibitors, Prognostic Marker, Therapeutic Target, aneuploidy, centrosome, chromosome, Testis Zinc Finger Protein (Tzfp), anaphase-promoting complex, phosphorylation, Cromosomal Passenger Complex, kinetochores, prometaphase, Survivin, INner CENtromere Pro-tein (INCENP), Histone Kinase, Tetrahymena thermophila, S. pombe, Saccharomyces cerevisiae, Drosophila, C. elegans, Xenopus, Spindle Checkpoint Kinase, microtubule-depolymerizing kinesin MCAK, Mi-totic Centromere-Associated Kinesin, Benzimidazoles, Cytokinesis Kinase, carcinoma, mesothelioma, glioblastoma, oral cancer, malignant en-dometrium, hepatocellular carcinoma, testicular germ, thyroid, colon, prostate, neoplastic lesions, Aurora Inhibitors, HESPERADIN, indolinone, chronic mye-loid leukemia (CML), acute lymphocytic leukemia
Current Medicinal Chemistry
Title: Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer
Volume: 18 Issue: 4
Author(s): G. Portella, C. Passaro and P. Chieffi
Affiliation:
Keywords: Aurora kinase, Aurora B, serine-threonine kinase, mitosis, cytokinesis, cancer, inhibitors, Prognostic Marker, Therapeutic Target, aneuploidy, centrosome, chromosome, Testis Zinc Finger Protein (Tzfp), anaphase-promoting complex, phosphorylation, Cromosomal Passenger Complex, kinetochores, prometaphase, Survivin, INner CENtromere Pro-tein (INCENP), Histone Kinase, Tetrahymena thermophila, S. pombe, Saccharomyces cerevisiae, Drosophila, C. elegans, Xenopus, Spindle Checkpoint Kinase, microtubule-depolymerizing kinesin MCAK, Mi-totic Centromere-Associated Kinesin, Benzimidazoles, Cytokinesis Kinase, carcinoma, mesothelioma, glioblastoma, oral cancer, malignant en-dometrium, hepatocellular carcinoma, testicular germ, thyroid, colon, prostate, neoplastic lesions, Aurora Inhibitors, HESPERADIN, indolinone, chronic mye-loid leukemia (CML), acute lymphocytic leukemia
Abstract: Aurora B is a serine-threonine kinase belonging to the highly conserved Aurora family of mitotic kinases. Aurora B is a chromosomal passenger protein involved in chromosome segregation, spindle-checkpoint, and cytokinesis. Alteration of each of these steps could induce aneuploidy, one of main features, and driving force of cancer progression. The overexpression of Aurora B has been observed in several tumor types, and has been linked with a poor prognosis of cancer patients. In this review we will focus on the role of Aurora B in cancer development, its role as a prognostic marker, and the clinical outcome of recently developed Aurora(s) inhibitors.
Export Options
About this article
Cite this article as:
Portella G., Passaro C. and Chieffi P., Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer, Current Medicinal Chemistry 2011; 18 (4) . https://dx.doi.org/10.2174/092986711794480203
| DOI https://dx.doi.org/10.2174/092986711794480203 |
Print ISSN 0929-8673 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Na, K-ATPase as a Biological Target for Gold(III) Complexes: A Theoretical and Experimental Approach
Current Medicinal Chemistry Clinical Pharmacogenetics of Methotrexate
Current Drug Metabolism Neuroprotective Gene Therapy for the Treatment of Inherited Retinal Degeneration
Current Gene Therapy Epigenetic Remodeling of Chromatin Architecture: Exploring Tumor Differentiation Therapies in Mesenchymal Stem Cells and Sarcomas
Current Stem Cell Research & Therapy Research Progress and Future Development Potential of Oridonin in Pharmacological Activities
Current Molecular Pharmacology Recent Patents Concerning Modulators of Protein Kinase C
Recent Patents on DNA & Gene Sequences Effect of Drugs in Cells and Tissues by NMR Spectroscopy
Current Topics in Medicinal Chemistry Glycosidated Phospholipids – a Promising Group of Anti-Tumour Lipids
Anti-Cancer Agents in Medicinal Chemistry The Role of Retinoids in the Adult Nervous System and their Therapeutic Potential
Mini-Reviews in Medicinal Chemistry ABC Transporters as Potential Targets for Modulation of Drug Resistance
Mini-Reviews in Medicinal Chemistry Therapeutic Antibodies
Current Molecular Medicine Topoisomerase II Inhibitors and Poisons, and the Influence of Cell Cycle Checkpoints
Current Medicinal Chemistry Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials
Current Cancer Drug Targets Bioinorganic Chemistry: The Study of the Fate of Platinum-Based Antitumour Drugs
Current Chemical Biology Cancer Stem Cells: Current Status and Therapeutic Implications in Cancer Therapy-A New Paradigm
Current Stem Cell Research & Therapy Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Current Neuropharmacology Cannabis Phenolics and their Bioactivities
Current Medicinal Chemistry Polymorphisms of Human N-Acetyltransferases and Cancer Risk
Current Drug Metabolism Serine-Threonine Protein Kinases CK1, CK2 and GSK3 in Normal and Malignant Haematopoiesis
Current Signal Transduction Therapy Innovative Drug Delivery Systems for the Administration of Natural Compounds
Current Bioactive Compounds

